CreChar AD - sustainable solution for waste management decarbonisation
CreChar AD - sustainable solution for waste management decarbonisation
批准号:
85160
负责人:
金额:
$9.98万
依托单位:
依托单位国家:
英国
项目类别:
Collaborative R&D
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Anaerobic digestion (AD) is a complex biotechnological process used to convert organic waste, such as food waste, unusable parts of plant crops and other farm-generated wastes as well as municipal wastewater into valuable biogas. Biogas is a renewable fuel with the potential to replace the natural gas necessary to heat our homes and power our industry.However, as any biological process AD is difficult to manage. Changes in feedstock type and quality present risks and can lead to complete process failure, which causes substantial losses in revenue and energy production, Most of the AD plants in the UK are currently working at maximum 65% digestion efficiency.During the COVID-19 pandemic, it became evident how important the AD industry is for managing organic waste disposal, but it also highlighted its limitations. Rapid changes in feedstocks during the crisis caused problems in AD plants, which resulted in high volumes of organic waste being sent to landfill or for incineration.Carbogenics' flagship product CreChar absorbs harmful chemicals and enhances the adaptive capability of the microorganisms that reside in biogas reactors, thereby stabilising the AD process and increasing biogas production by 15%. We produce CreChar sustainably from difficult-to recycle paper- based waste such as food- contaminated cardboard boxes or waste paper cups. Our innovative product will enable the AD industry to deal with abrupt feedstock regime changes much better. CreChar will make the AD sector more resilient and allow it to effectively respond to waste management emergencies like the COVID-19 pandemic, while also generating additional revenue of £200k/annum (for an average 1MGW plant). After its use in AD, our product can be safely deposited in soils, realising significant carbon savings.Our Innovate UK project will initially focus on lab-based customisation of our CreChar product, followed by demonstration of its capability with an industrial partner in a full-scale trial. The project will accelerate CreChar's commercialisation, bringing our innovation to the market as early as 2021\. Our circular economy business will contribute to the decarbonisation of the economy, thereby helping to reach the UK's net zero CO2 emissions and zero waste targets by 2050\.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
当归芍药散经TrkB/Akt通路调节AD中枢葡萄糖代谢的认知保护机制研究
-
批准号:2026JJ60631
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王亚晗
-
依托单位:
基于 LnCRNA TUG1/KLF2 途径探讨小胶质细胞在 AD 中的炎性活化机制及阿司匹林姜黄素酯抗炎机制研究
-
批准号:2026JJ70134
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贺春香
-
依托单位:
基于“SCFAs-小胶质细胞-Th17/Treg免疫细胞轴”探讨异功散调控AD神经炎症的作用机制
-
批准号:2026JJ82392
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:任香怡
-
依托单位:
Apelin-13抑制小胶质细胞NLRP3炎症小体激活引起的神经炎症改善AD
-
批准号:2026JJ81243
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:蒋彭成
-
依托单位:
有氧运动联合生慧汤调控SIRT1/Nrf2/GPX4信号通路抑制铁死亡减轻AD小鼠神经元突触损伤的机制研究
-
批准号:JCZRLH202600579
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
新型NLRP3蛋白降解剂ND3的活性验证与抗AD药效学研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程兆炎
-
依托单位:
蓝斑核-NE能系统中RTN3介导慢性疼痛加重AD小鼠认知障碍的机制研究
-
批准号:2026JJ82038
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:尹坚银
-
依托单位:
SIRT1/NLRP3通路介导小胶质细胞极化在肾脑复元汤改善AD小鼠认知功能障碍中的作用及机制研究
-
批准号:JCZRLH202601602
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
“益肾调督”电针法调控AMPK/HIF-1a信号轴介导小胶质细胞糖代谢改善AD突触可塑性的作用机制
-
批准号:JCZRLH202600730
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
p-香豆酸通过激活TRIM24介导TRAF3泛素化减轻淀粉样蛋白诱导的神经元损伤以缓解AD进展
-
批准号:2026JJ80213
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭尹娜
-
依托单位: